4DMedical Limited Share Price
Stocks
4DX
AU0000095416
Advanced Medical Equipment & Technology
OTC Markets Traded|
Delayed
Australian S.E.
00:59:05 08/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 3.430 AUD | -2.56% |
|
+0.29% | -12.72% |
| 08-28 | 4DMedical Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 08-28 | 4DMedical Fiscal 2026 Loss Narrows, Revenue Up; Shares Gain 3% | MT |
| Market Cap | 2.11B 1.52B 1.31B 1.23B 1.12B 2.1B 144B 14.61B 5.65B 73.78B 5.72B 5.6B 235B | P/E 2026 |
-151x | P/E 2027 * | -56.8x |
|---|---|---|---|---|---|
| Enterprise Value | 1.85B 1.33B 1.15B 1.08B 984M 1.84B 126B 12.78B 4.94B 64.53B 5B 4.89B 206B | EV / Sales 2026 |
344x | EV / Sales 2027 * | 82.2x |
| Free-Float |
93.62% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| 4DX | Delayed | |
OTC Markets
| FDMDF | Delayed | |
|
Tradegate
| MQ7 | Real-time | |
|
Deutsche Boerse AG
| MQ7 | Delayed | |
|
Boerse Muenchen
| MQ7 | Real-time |
Last Transcript : 4DMedical Limited
| 1 day | -2.56% | ||
| 1 week | +0.29% | ||
| Current month | +0.29% | ||
| 1 month | -18.72% | ||
| 3 months | -14.46% | ||
| 6 months | -15.52% | ||
| Current year | -12.72% |
| 1 week | 3.31 |  | 3.67 |
| 1 month | 3.31 | | 4.47 |
| Current year | 2.95 | | 7.55 |
| 1 year | 1.4 | | 7.55 |
| 3 years | 0.22 | | 7.55 |
| 5 years | 0.22 | | 7.55 |
| 10 years | 0.22 | | 7.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andreas Fouras
CEO | Chief Executive Officer | - | 30/11/2012 |
Julian Sutton
DFI | Director of Finance/CFO | - | 01/01/2026 |
Greg Mogel
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Andreas Fouras
BRD | Director/Board Member | - | 30/11/2012 |
Lilian Bianchi
CHM | Chairman | - | 01/11/2023 |
John Livingston
BRD | Director/Board Member | - | 30/09/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/06/26 | Buy | Chief Financial Officer | 13,054 | 0.0022% | ||
| 04/03/26 | Exercice | Director | 213,464 | 0.0373% | ||
| 04/03/26 | Exercice | Director | 213,464 | 0.0373% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.56% | +0.29% | +48.48% | +462.30% | 1.56B | |
| -0.75% | -1.35% | +24.60% | +14.36% | 227B | |
| -1.60% | -3.89% | +3.72% | -19.20% | 146B | |
| -0.85% | -1.58% | -21.45% | +19.12% | 130B | |
| +1.81% | +2.05% | -55.42% | -11.25% | 69.27B | |
| +0.13% | -0.34% | +11.07% | +16.81% | 51.82B | |
| -0.97% | -2.28% | -18.25% | -14.22% | 50.45B | |
| +0.59% | -1.94% | +17.17% | +27.91% | 42.53B | |
| -1.01% | -1.28% | +33.64% | +50.03% | 40.22B | |
| -1.55% | +1.22% | +120.58% | +36.40% | 32.95B | |
| Average | -0.68% | -0.95% | +16.42% | +58.23% | 79.13B | |
| Weighted average by Cap. | -0.63% | -1.41% | +6.69% | +9.39% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 8.34M 6.02M 5.18M 4.87M 4.44M 8.31M 569M 57.73M 22.32M 292M 22.61M 22.11M 929M | 22.8M 16.46M 14.15M 13.31M 12.15M 22.73M 1.56B 158M 61.01M 797M 61.8M 60.45M 2.54B |
| Net income | -177M -128M -110M -103M -94.36M -176M -12.09B -1.23B -474M -6.19B -480M -469M -19.71B | -38.5M -27.79M -23.9M -22.48M -20.52M -38.38M -2.63B -267M -103M -1.35B -104M -102M -4.29B |
| Net Debt | -264M -191M -164M -154M -141M -264M -18.05B -1.83B -708M -9.24B -717M -701M -29.45B | -236M -170M -147M -138M -126M -235M -16.12B -1.64B -632M -8.26B -640M -626M -26.3B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/09/26 | A$3.430 | -2.56% | 117,798 |
| 07/09/26 | A$3.520 | -2.22% | 1,972,748 |
| 04/09/26 | A$3.600 | +4.65% | 4,702,006 |
| 03/09/26 | A$3.440 | +1.47% | 3,008,017 |
| 02/09/26 | A$3.390 | -0.88% | 4,034,406 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4DX Stock
Select your edition
All financial news and data tailored to specific country editions
